Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.34M Hold
18,933
0.86% 22
2025
Q2
$5.22M Buy
18,933
+1,193
+7% +$338K 0.86% 23
2025
Q1
$5.53M Buy
17,740
+89
+0.5% +$26.3K 1.2% 23
2024
Q4
$4.63M Buy
17,651
+128
+0.7% +$38K 0.98% 24
2024
Q3
$5.57M Buy
+17,523
New +$5.73M 1.21% 19
2024
Q1
$5.47M Buy
+17,581
New +$5.14M 1.69% 14

Other funds holding AMGN

Watts Gwilliam & Co's AMGN Position: Q3 2025 in Review

Watts Gwilliam & Co held its Amgen (AMGN) position steady in Q3 2025 at 18,933 shares worth $5.34M. The position accounts for 0.86% of the portfolio, ranked #22.

Watts Gwilliam & Co first reported a position in AMGN in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.57M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Watts Gwilliam & Co held 18,933 shares of Amgen worth $5.34M as of Q3 2025.
  • Watts Gwilliam & Co left its Amgen share count unchanged in Q3 2025.
  • Amgen made up 0.86% of Watts Gwilliam & Co's portfolio in Q3 2025, its #22 holding.
  • Watts Gwilliam & Co first reported a position in Amgen in Q1 2024 and has held it in 6 quarters since.
  • Watts Gwilliam & Co's Amgen position peaked at $5.57M in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Watts Gwilliam & Co's 13F filing for Q3 2025, filed 21 Nov 2025.